S. 527
119th Congress
Senate
Prescription Pricing for the People Act of 2025
Official title: A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate pol… Show full official titleShow less
Official title: A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Commerce
Business ethicsBusiness recordsCompetition and antitrustCongressional oversight
More subjectsShow fewer subjects
Consumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesPrescription drugsRetail and wholesale tradesSupply chain
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 10, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
Apr 10, 2025
Committee on the Judiciary. Reported by Senator Grassley without amendment. Without written report.
Apr 3, 2025
Committee on the Judiciary. Ordered to be reported without amendment favorably.
Feb 11, 2025
Read twice and referred to the Committee on the Judiciary.
Feb 11, 2025
Introduced in Senate
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
What's happening now
Placed on Senate Legislative Calendar under General Orders. Calendar No. 42.
Bill text
2 versions
- Introduced in Senate Formatted Text PDF Formatted XML
- Reported to Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
1
Lobbying activity
77
- NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
- BIOTECHNOLOGY INNOVATION ORGANIZATION
- NATIONAL ASSOCIATION OF CHAIN DRUG STORES
- AMERICAN COLLEGE OF RHEUMATOLOGY
- COUNCIL FOR INNOVATION PROMOTION (C4IP)
- AMERICAN MEDICAL ASSOCIATION
Bodies those filers lobbied
- HOUSE OF REPRESENTATIVES
- SENATE
- Centers For Medicare and Medicaid Services (CMS)
- Health & Human Services, Dept of (HHS)
- White House Office
- Treasury, Dept of
- Food & Drug Administration (FDA)
- Office of Management & Budget (OMB)
Cite this page
U.S. Congress. (2026). S. 527: Prescription Pricing for the People Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-527/
"S. 527: Prescription Pricing for the People Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-527/.
S. 527, 119th Cong. (2026), https://openamerica.io/bill/119-S-527/.
[S. 527: Prescription Pricing for the People Act of 2025](https://openamerica.io/bill/119-S-527/)